LARP1 and cancer: RBPs like LARP1, which selectively regulate the stability of multiple mRNA transcripts, are exciting potential therapeutic targets, as their inhibition could simultaneously target multiple oncogenic pathways.5 By acting at a point of convergence of multiple cancer signaling cascades, LARP1 is an important post-transcriptional regulator of cancer progression and may prove to be a target for therapeutic intervention.